Bliss GVS Pharma has informed that pursuant to the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited (the Company) will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Wednesday, April 01, 2026 till completion of 48 hours after the announcement of the Audited Financial Results of the Company for the financial year ended March 31, 2026, generally made available to the public. The date of the Board Meeting for consideration of the Audited Financial Results of the Company for the financial year ended March 31, 2026, will be intimated later. Accordingly, Insiders, Designated Persons, and their immediate relatives are advised not to trade (buy or sell or pledge, etc.) in the securities/ shares of the Company during the aforesaid period of closure of the Trading Window.

The above information is a part of company’s filings submitted to BSE.